HOME >> BIOLOGY >> NEWS
Ohio researcher receives national award

Pioneered addition of fluoride to toothpaste

M. David Francis of Wyoming, Ohio, will be honored on August 20 by the world's largest scientific society for his pioneering role in developing fluoride additives for toothpaste, bone-strengthening pharmaceuticals and other medical products. He will be designated one of 12 Heroes of Chemistry by the American Chemical Society at its 220th national meeting, in Washington, D.C.

"My original work was in dentistry," said Francis, a physical biochemist who began a career with Proctor & Gamble in 1952. Products based on his findings include two of the most widely used toothpastes: Advanced Formula Crest and Tartar Control Crest.

In nominating him for the award, Joel Shulman, P&G's external affairs manager, wrote: "Dr. Francis' research on the chemistry of tooth enamel structure and formation, and on the mechanism by which the fluoride ion interferes with the destruction of tooth enamel and dentin, played a role in the widespread adoption of fluoride therapies throughout the United States and the world." Shulman noted that cavities among U.S. children have dropped 80 percent since 1967.

"When we found out how [such additives] operated on dental enamel, it was a small jump to see the same thing happen with bone," said Francis. His efforts led to new compounds called bisphosphonates, which treat a variety of bone diseases.

The body constantly recycles its skeletal structure, breaking down old bone tissue and replacing it with new. In disorders like Paget's disease, however, resorption and formation are accelerated, and bones become soft, porous and misshapen.

One of Francis' discoveries, marketed as Didronel, bonds to bone surfaces to slow bone resorption and allow for normal formation. It is approved in 26 countries to help stop age-related bone loss, or osteoporosis. A related product, Osteoscan, is used to delineate patients' bone structure. The bisphosphonate molecule carries a ra
'"/>

Contact: Christina Curtin
c_curtin@acs.org
202-872-4400
American Chemical Society
17-Aug-2000


Page: 1 2

Related biology news :

1. Belgian researchers explore revolutionary approach to angiogenesis
2. Award winning researchers reveal potential new role for Glivec
3. University of Alberta researcher looks for clues to mysterious disease
4. $7.5 Million grant to Yale researchers for role of viruses in cancer
5. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
6. Joslin researchers clarify mechanisms for beta-cell formation
7. Pioneering AIDS researcher to speak at UH
8. Defensive action by influenza viruses demonstrated by Hebrew university researcher
9. Virginia Tech researchers to release findings on Smith River Project
10. Molecular motor myosin VI moves hand over hand, researchers say
11. Tiny molecules have big potential as cancer drugs, Stanford researcher believes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ohio researcher receives national award

(Date:8/21/2014)... the journal Carcinogenesis by researchers at the ... protein adenomatous polyposis coli (APC) in suppressing colorectal cancer ... U.S. , Lead author Kristi Neufeld, associate professor in ... Cancer Biology program at the KU Cancer Center, has ... understand the various activities of APC, a protein whose ...
(Date:8/21/2014)... A team of researchers at Louisiana Tech ... using affordable, consumer-grade 3D printers and materials ... contain antibacterial and chemotherapeutic compounds for targeted ... doctoral students and research faculty from Louisiana ... collaborated to create filament extruders that can ...
(Date:8/21/2014)... State University have developed a novel and versatile modeling ... for creating new materials as well as for studying ... allows us to model much larger and more complex ... says Nan Li, lead author of a paper on ... Department of Materials Science and Engineering. "This is a ...
Breaking Biology News(10 mins):Research offers insight into cellular biology of colorectal cancer 2Research offers insight into cellular biology of colorectal cancer 3Louisiana Tech University researchers use 3D printers to create custom medical implants 2Louisiana Tech University researchers use 3D printers to create custom medical implants 3Researchers develop models to study polyelectrolytes, including DNA and RNA 2
(Date:8/21/2014)... 2014 Deep Research Report ... professional and in-depth research report on the ... Seaweed Fertilizer information, including Seaweed Fertilizer definition, ... well as industry overview. This research covers ... as well as global industry analysis covering ...
(Date:8/21/2014)... The College of New Rochelle announced ... the Mid-Hudson Region to be designated as a START-UP ... from qualified “high-technology” businesses that align with the College’s ... have been selected for the START-UP NY program and ... stimulate economic development in New York by growing business ...
(Date:8/21/2014)... -- China Cord Blood Corporation (NYSE: CO ) ... results for the first quarter of fiscal year 2015 ... the US.  The Company will host ... August 29, 2014 to discuss its financial performance and ... followed by a question and answer session.  Interested parties ...
(Date:8/21/2014)... August 21, 2014 Gallus ... contract development and manufacturing organization (CMO) announced today ... Inc., an oncology company focused on the development ... to manufacture the anti-prostate specific membrane antigen (PSMA) ... candidate. Under the agreement the antibody will ...
Breaking Biology Technology:Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com 2Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com 3The College of New Rochelle Becomes First Private College in Mid-Hudson Region to Earn START-UP NY Designation 2The College of New Rochelle Becomes First Private College in Mid-Hudson Region to Earn START-UP NY Designation 3China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 3
Cached News: